Literature DB >> 9461086

Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I.

M R Persey1, D R Booth, S E Booth, R van Zyl-Smit, B K Adams, A B Fattaar, G A Tennent, P N Hawkins, M B Pepys.   

Abstract

We report a family with autosomal-dominant hereditary systemic amyloidosis in three generations, presenting with renal involvement. Two members of the current generation received renal transplants for end-stage renal failure 16 and 18 years ago, and remain very well clinically despite massive visceral amyloidosis. Two other members of this generation, aged 32 and 47 years, have massive systemic amyloid but no clinical disability. Individuals known to be affected in previous generations died of renal failure in early adult life. Amyloid deposits in the proband, one of the transplanted individuals, were composed of apolipoprotein A-I (apoA-I), and among living family members there was complete concordance between amyloidosis and the presence of a novel 9 base pair in-frame deletion mutation in exon 4 of the apoA-I gene, causing a loss of residues Glu70Phe71Trp72. This predicts the acquisition of a single extra positive charge by mature apoA-I, and this variant was detected in the plasma of all carriers. All the previously reported amyloidogenic variants of apoA-I also carry an extra positive charge, indicating that this electrostatic change is likely to be relevant to the amyloidogenicity of apoA-I.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461086     DOI: 10.1046/j.1523-1755.1998.00770.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

1.  Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure.

Authors:  P Mangione; M Sunde; S Giorgetti; M Stoppini; G Esposito; L Gianelli; L Obici; L Asti; A Andreola; P Viglino; G Merlini; V Bellotti
Journal:  Protein Sci       Date:  2001-01       Impact factor: 6.725

Review 2.  A novel amyloidogenic variant of apolipoprotein AI: implications for a conformational change leading to cardiomyopathy.

Authors:  M T Walsh
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

3.  Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis.

Authors:  M M de Sousa; C Vital; D Ostler; R Fernandes; J Pouget-Abadie; D Carles; M J Saraiva
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Lipoprotein abnormalities in patients with secondary renal amyloidosis.

Authors:  K Cengiz; A Bakan; H Yilmaz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

5.  Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation.

Authors:  Nicole K Andeen; Daniel Y Lam; Ian H de Boer; Roberto F Nicosia
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

6.  Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.

Authors:  Dorota Rowczenio; Ahmet Dogan; Jason D Theis; Julie A Vrana; Helen J Lachmann; Ashutosh D Wechalekar; Janet A Gilbertson; Toby Hunt; Simon D J Gibbs; Prayman T Sattianayagam; Jenny H Pinney; Philip N Hawkins; Julian D Gillmore
Journal:  Am J Pathol       Date:  2011-08-05       Impact factor: 4.307

7.  Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis.

Authors:  Julian D Gillmore; Helen J Lachmann; Dorota Rowczenio; Janet A Gilbertson; Cai-Hong Zeng; Zhi-Hong Liu; Lei-Shi Li; Ashutosh Wechalekar; Philip N Hawkins
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

8.  Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.

Authors:  Magdalena Eriksson; Stefan Schönland; Saniye Yumlu; Ute Hegenbart; Hanna von Hutten; Zarina Gioeva; Peter Lohse; Janine Büttner; Hartmut Schmidt; Christoph Röcken
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

9.  Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1.

Authors:  L Hamidi Asl; J J Liepnieks; K Hamidi Asl; T Uemichi; G Moulin; E Desjoyaux; R Loire; M Delpech; G Grateau; M D Benson
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

10.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases.

Authors:  Fabrizio Chiti; Martino Calamai; Niccolo Taddei; Massimo Stefani; Giampietro Ramponi; Christopher M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.